Active, not recruiting
Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSD
NCT06724809
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cranial Nerve Diseases, +11 more
- Locations
-
- Research Site Beijing, China
- Research Site Dongguan, China
- Research Site Jinan, China
- Research Site Shanghai, China